These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


392 related items for PubMed ID: 26185006

  • 1. Synthesis and evaluation of isatin-β-thiosemicarbazones as novel agents against antibiotic-resistant Gram-positive bacterial species.
    Zhang XM, Guo H, Li ZS, Song FH, Wang WM, Dai HQ, Zhang LX, Wang JG.
    Eur J Med Chem; 2015 Aug 28; 101():419-30. PubMed ID: 26185006
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones.
    Thanh ND, Giang NTK, Quyen TH, Huong DT, Toan VN.
    Eur J Med Chem; 2016 Nov 10; 123():532-543. PubMed ID: 27517802
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Synthesis of 1H-1,2,3-Triazole-Linked Quinoline-Isatin Molecular Hybrids as Anti-Breast Cancer and Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Agents.
    Awolade P, Cele N, Ebenezer O, Kerru N, Gummidi L, Gu L, Palma G, Kaur M, Singh P.
    Anticancer Agents Med Chem; 2021 Nov 10; 21(10):1228-1239. PubMed ID: 32990543
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Design and synthesis of benzenesulfonanilides active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus.
    Namba K, Zheng X, Motoshima K, Kobayashi H, Tai A, Takahashi E, Sasaki K, Okamoto K, Kakuta H.
    Bioorg Med Chem; 2008 Jun 01; 16(11):6131-44. PubMed ID: 18468909
    [Abstract] [Full Text] [Related]

  • 9. Action mechanism of 6, 6'-dihydroxythiobinupharidine from Nuphar japonicum, which showed anti-MRSA and anti-VRE activities.
    Okamura S, Nishiyama E, Yamazaki T, Otsuka N, Taniguchi S, Ogawa W, Hatano T, Tsuchiya T, Kuroda T.
    Biochim Biophys Acta; 2015 Jun 01; 1850(6):1245-52. PubMed ID: 25731981
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological evaluation of spiropyrimidinetriones oxazolidinone derivatives as antibacterial agents.
    Siddiqui AM, Sattigeri JA, Javed K, Shafi S, Shamim M, Singhal S, Malik ZM.
    Bioorg Med Chem Lett; 2018 Apr 15; 28(7):1198-1206. PubMed ID: 29525219
    [Abstract] [Full Text] [Related]

  • 12. Synthesis, anti-MRSA, and anti-VRE activity of hemin conjugates with amino acids and branched peptides.
    Okorochenkov SA, Zheltukhina GA, Mirchink EP, Isakova EB, Feofanov AV, Nebolsin VE.
    Chem Biol Drug Des; 2013 Oct 15; 82(4):410-7. PubMed ID: 23663365
    [Abstract] [Full Text] [Related]

  • 13. Purification and characterization of actinomycins from Streptomyces strain M7 active against methicillin resistant Staphylococcus aureus and vancomycin resistant Enterococcus.
    Sharma M, Manhas RK.
    BMC Microbiol; 2019 Feb 19; 19(1):44. PubMed ID: 30782119
    [Abstract] [Full Text] [Related]

  • 14. Structure-activity relationship of the aminomethylcyclines and the discovery of omadacycline.
    Honeyman L, Ismail M, Nelson ML, Bhatia B, Bowser TE, Chen J, Mechiche R, Ohemeng K, Verma AK, Cannon EP, Macone A, Tanaka SK, Levy S.
    Antimicrob Agents Chemother; 2015 Nov 19; 59(11):7044-53. PubMed ID: 26349824
    [Abstract] [Full Text] [Related]

  • 15. [In vitro activity of daptomycin against VRE and MRSA strains].
    Aktaş G, Derbentli S.
    Mikrobiyol Bul; 2014 Jan 19; 48(1):123-8. PubMed ID: 24506722
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and antibacterial studies of binaphthyl-based tripeptoids. Part 1.
    Bremner JB, Keller PA, Pyne SG, Boyle TP, Brkic Z, David DM, Robertson M, Somphol K, Baylis D, Coates JA, Deadman J, Jeevarajah D, Rhodes DI.
    Bioorg Med Chem; 2010 Apr 01; 18(7):2611-20. PubMed ID: 20236828
    [Abstract] [Full Text] [Related]

  • 17. Structure optimizing of flavonoids against both MRSA and VRE.
    Wei MZ, Zhu YY, Zu WB, Wang H, Bai LY, Zhou ZS, Zhao YL, Wang ZJ, Luo XD.
    Eur J Med Chem; 2024 May 05; 271():116401. PubMed ID: 38640870
    [Abstract] [Full Text] [Related]

  • 18. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
    Wang Z, Cao B, Liu YM, Gu L, Wang C.
    Chin Med J (Engl); 2009 Jun 05; 122(11):1283-8. PubMed ID: 19567138
    [Abstract] [Full Text] [Related]

  • 19. Time-kill kinetics of oritavancin and comparator agents against Staphylococcus aureus, Enterococcus faecalis and Enterococcus faecium.
    McKay GA, Beaulieu S, Arhin FF, Belley A, Sarmiento I, Parr T, Moeck G.
    J Antimicrob Chemother; 2009 Jun 05; 63(6):1191-9. PubMed ID: 19369269
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of nemonoxacin (TG-873870), a novel non-fluorinated quinolone, against clinical isolates of Staphylococcus aureus, enterococci and Streptococcus pneumoniae with various resistance phenotypes in Taiwan.
    Chen YH, Liu CY, Lu JJ, King CH, Hsueh PR.
    J Antimicrob Chemother; 2009 Dec 05; 64(6):1226-9. PubMed ID: 19833635
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.